Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.21.2
Consolidated Balance Sheets - USD ($)
Aug. 31, 2021
Nov. 30, 2020
Current Assets    
Cash and cash equivalents $ 7,700,806 $ 10,361,125
Marketable securities 74,124 88,476
Accounts receivable (net of allowance for doubtful accounts of $2,896,051 and $2,781,668, respectively) 5,449,313 6,322,960
Prepaid expenses 513,009 611,627
Inventory, current portion 833,963 927,318
Other current assets 349,695 244,696
Total current assets 14,920,910 18,556,202
Property and Equipment-net 3,028,268 1,640,774
Other Assets    
Duke license agreement 14,891,995  
Intangible assets, net 1,572,804 1,181,588
Inventory, net of current portion 10,855,900 11,064,034
Goodwill 1,941,411 1,941,411
Deferred tax assets 10,363,967 10,363,967
Operating lease right-of-use asset 992,346 299,089
Deposits and other assets, net 548,429 495,029
Total other assets 41,474,852 26,003,118
Total assets 59,424,030 46,200,094
Current Liabilities    
Accounts payable 999,118 957,390
Accrued expenses 1,646,916 2,898,211
Current portion of note payable 2,663,676 3,100,000
Current portion of operating lease liability 306,817 275,570
Current portion of Duke license agreement liability 4,915,542  
Deferred revenue 9,326,124 9,183,450
Total current liabilities 19,858,193 16,414,621
Other Liabilities    
Deferred revenue, net of current portion 30,395,653 27,200,910
Contingent consideration 905,743 1,509,852
Note payable, net of current portion and debt issuance costs   2,841,214
Operating lease long-term liability 690,347 23,632
Long-term liability - revenue sharing agreements 875,000 875,000
Total other liabilities 34,767,095 32,450,608
Total liabilities 54,625,288 48,865,229
Commitments and contingencies (Note 9) 0 0
Stockholders' Equity (Deficit)    
Preferred stock 0 0
Common stock ($.01 par value, 20,000,000 authorized; 14,617,672 issued and 8,529,647 outstanding as of August 31, 2021 and 13,633,638 issued and 7,545,613 outstanding as of November 30, 2020) 146,177 136,336
Additional paid-in capital 41,314,923 36,581,600
Treasury stock, at cost (20,563,357) (20,563,357)
Accumulated deficit (16,099,001) (18,819,714)
Total stockholders' equity (deficit) 4,798,742 (2,665,135)
Total liabilities and stockholders' equity (deficit) 59,424,030 46,200,094
Series A Junior Participating Preferred Stock [Member]    
Stockholders' Equity (Deficit)    
Preferred stock 0 0
Tianhe Stem Cell Biotechnologies Inc [Member]    
Other Assets    
Investment 308,000 308,000
Patent Option Agreement [Member]    
Other Assets    
Investment   $ 350,000
Duke University [Member]    
Other Liabilities    
Duke license agreement liability $ 1,900,352